Memantine and Zoledronic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Memantine (memantine) and Zoledronic acid (zoledronic acid). Common drug interactions include dry skin among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Memantine and Zoledronic acid. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Memantine?

Memantine has active ingredients of memantine. It is often used in alzheimer's disease. eHealthMe is studying from 10,266 Memantine users. Check the latest studies of Memantine.

What is Zoledronic acid?

Zoledronic acid has active ingredients of zoledronic acid. eHealthMe is studying from 28,485 Zoledronic acid users. Check the latest studies of Zoledronic acid.

On Jul, 15, 2026

14 people who take Memantine and Zoledronic acid together, and have interactions are studied.

Memantine and Zoledronic acid drug interactions.

What are the common drug interactions of Memantine and Zoledronic Acid, by gender? *:

female:

Dry skin
Dyspnoea (difficult or laboured respiration)
Flushing (the warm, red condition of human skin)
Headache (pain in head)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)
Neck pain
Skin warm
Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)

male:

Pneumonia
Febrile neutropenia (fever with reduced white blood cells)
Herpes zoster
Malaise (a feeling of general discomfort or uneasiness)
Pain

What are the common drug interactions of Memantine and Zoledronic Acid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Febrile neutropenia (fever with reduced white blood cells)
Pneumonia

50-59:

n/a

60+:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Anxiety
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)
Neck pain
Skin warm
Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
Staphylococcal infection (an infection with staphylococcus bacteria)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Tremor (trembling or shaking movements in one or more parts of your body)

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 42.86%
Multiple Myeloma (cancer of the plasma cells): 5 people, 35.71%
Encephalopathy (functioning of the brain is affected by some agent or condition): 5 people, 35.71%
High Blood Pressure: 5 people, 35.71%
Leukopenia (less number of white blood cells in blood): 4 people, 28.57%
Blood Magnesium Decreased: 4 people, 28.57%
Breast Cancer: 4 people, 28.57%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 28.57%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 28.57%
Hypokalemia (low potassium): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Memantine and Zoledronic acid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously